333 related articles for article (PubMed ID: 21848914)
1. Targeting glioma stem cells: a novel framework for brain tumors.
Binello E; Germano IM
Cancer Sci; 2011 Nov; 102(11):1958-66. PubMed ID: 21848914
[TBL] [Abstract][Full Text] [Related]
2. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
3. Glioma stem cell maintenance: the role of the microenvironment.
Heddleston JM; Hitomi M; Venere M; Flavahan WA; Yang K; Kim Y; Minhas S; Rich JN; Hjelmeland AB
Curr Pharm Des; 2011; 17(23):2386-401. PubMed ID: 21827414
[TBL] [Abstract][Full Text] [Related]
4. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
5. Specific Preferences in Lineage Choice and Phenotypic Plasticity of Glioma Stem Cells Under BMP4 and Noggin Influence.
Videla Richardson GA; Garcia CP; Roisman A; Slavutsky I; Fernandez Espinosa DD; Romorini L; Miriuka SG; Arakaki N; Martinetto H; Scassa ME; Sevlever GE
Brain Pathol; 2016 Jan; 26(1):43-61. PubMed ID: 25808628
[TBL] [Abstract][Full Text] [Related]
6. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
7. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
[TBL] [Abstract][Full Text] [Related]
9. Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma.
Sørensen MD; Fosmark S; Hellwege S; Beier D; Kristensen BW; Beier CP
Adv Exp Med Biol; 2015; 853():111-38. PubMed ID: 25895710
[TBL] [Abstract][Full Text] [Related]
10. Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.
Cattaneo M; Baronchelli S; Schiffer D; Mellai M; Caldera V; Saccani GJ; Dalpra L; Daga A; Orlandi R; DeBlasio P; Biunno I
J Biol Chem; 2014 Jan; 289(5):2826-38. PubMed ID: 24311781
[TBL] [Abstract][Full Text] [Related]
11. Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.
Yao XH; Liu Y; Chen K; Gong W; Liu MY; Bian XW; Wang JM
Int Immunopharmacol; 2011 Dec; 11(12):1961-6. PubMed ID: 21930249
[TBL] [Abstract][Full Text] [Related]
12. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
13. Response-predictive gene expression profiling of glioma progenitor cells in vitro.
Moeckel S; Meyer K; Leukel P; Heudorfer F; Seliger C; Stangl C; Bogdahn U; Proescholdt M; Brawanski A; Vollmann-Zwerenz A; Riemenschneider MJ; Bosserhoff AK; Spang R; Hau P
PLoS One; 2014; 9(9):e108632. PubMed ID: 25268354
[TBL] [Abstract][Full Text] [Related]
14. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.
Filatova A; Acker T; Garvalov BK
Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585
[TBL] [Abstract][Full Text] [Related]
15. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
16. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for glioma stem cells.
Rizzo AE; Yu JS
Adv Exp Med Biol; 2015; 853():85-110. PubMed ID: 25895709
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of glioma-associated neovascularization.
Hardee ME; Zagzag D
Am J Pathol; 2012 Oct; 181(4):1126-41. PubMed ID: 22858156
[TBL] [Abstract][Full Text] [Related]
19. Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar.
Hira VVV; Aderetti DA; van Noorden CJF
J Histochem Cytochem; 2018 May; 66(5):349-358. PubMed ID: 29328867
[TBL] [Abstract][Full Text] [Related]
20. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
